SCHEMBL9897703

SCHEMBL9897703

COCC(=O)N[C@H]1CC[C@H](NC(=O)c2c(C)[nH]c3c(-c4cc(F)c(OC)cc4OCC4CC4)ncnc23)CC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 3/20 0.34
GRIN2B Q13224 3/20 0.34
HTR2A P28223 2/20 0.33
ACACB O00763 1/20 0.33
DRD3 P35462 1/20 0.33
SMO Q99835 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
HTR2C P28335 1/20 0.32
HTR2B P41595 1/20 0.32
LDHA P00338 1/20 0.32
PDE4B Q07343 2/20 0.32
PDE4D Q08499 1/20 0.32
SCN9A Q15858 2/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
RIPK2 O43353 1/20 0.32
LRRK2 Q5S007 1/20 0.31
RBP4 P02753 1/20 0.31
TTR P02766 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9896848 1.00 GRIN1 (0.34) GRIN1GRIN2BHTR2AACACBDRD3
SCHEMBL9896846 1.00 GRIN1 (0.34) GRIN1GRIN2BHTR2AACACBDRD3
SCHEMBL9896608 0.97 GRIN1 (0.34) GRIN1GRIN2BHTR2AACACBDRD3
SCHEMBL9899171 0.97 GRIN1 (0.34) GRIN1GRIN2BHTR2AACACBDRD3
SCHEMBL9896605 0.97 GRIN1 (0.34) GRIN1GRIN2BHTR2AACACBDRD3
SCHEMBL9896410 0.94 GRIN1 (0.35) GRIN1GRIN2BHTR2AHTR2CHTR2B
SCHEMBL9896408 0.94 GRIN1 (0.35) GRIN1GRIN2BHTR2AHTR2CHTR2B
SCHEMBL9897628 0.94 GRIN1 (0.35) GRIN1GRIN2BHTR2AHTR2CHTR2B
SCHEMBL9896990 0.93 GRIN1 (0.34) GRIN1GRIN2BHTR2AHTR2CHTR2B
SCHEMBL9898767 0.93 GRIN1 (0.34) GRIN1GRIN2BHTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9376442-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2016-06-28 US claimed
US-20150073001-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES ASTRAZENECA AB (SE) 2015-03-12 US claimed
US-8927557-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2015-01-06 US claimed
EP-2470536-B1 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2014-11-12 EP claimed
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-14 US claimed
US-9376442-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2016-06-28 US disclosed
US-20150073001-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES ASTRAZENECA AB (SE) 2015-03-12 US disclosed
US-8927557-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2015-01-06 US disclosed
EP-2470536-B1 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2014-11-12 EP disclosed
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE12, PDE4A GRIN1 2957/4885GRIN2B 2922/4885HTR2A 2043/4885
US-20150073001-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES PDE12, PDE5A, PDE4A GRIN1 4046/4885GRIN2B 4241/4885HTR2A 3746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.